Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

<< Previous

Bullboard Posts

Next >>

Post by Humaniston Feb 19, 2021 4:20pm

230 Views

Post# 32612935

Seeking alpha: february 23/2pm cannabis sector web/BY COWEN

Tuesday - February 23

2:00 p.m. A Cowen webinar on the cannabis market and interstate commerce is set to delve into the various options that Congress is considering to legalize cannabis. Whether the cannabis issue is deferred to states or cannabis is either removed from the list of controlled substances or pushed to a lower tier could have significant ramifications for sector players like Tilray (NASDAQ:TLRY),
Aphria (NASDAQ:APHA), Canopy Growth (NYSE:CGC), Cronos Group (NASDAQ:CRON), Aurora Cannabis (NYSE:ACB) and HEXO Corp. (NYSE:HEXO). Cowen is bringing in George Washington University law professor Jonathan Turley to walk investors through some of the legal issues. The follow-up note on the sector from the Cowen analyst team could jolt shares prices.